Trial site
Hospital Universitario Quirónsalud Madrid
- 6running trials
- 13closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer3 trials
- Acute myeloid leukaemia2 trials
- Bladder cancer2 trials
- Chronic lymphocytic leukaemia2 trials
- Endometrial cancer2 trials
- Follicular lymphoma2 trials
- Head and neck cancer2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- Atopic dermatitis (eczema)1 trial
- Cervical cancer1 trial
- and 12 more
- Phase
- Phase 26 trials
- Phase 15 trials
- Phase 1/24 trials
- Phase 33 trials
- Status
- Completed9 trials
- Recruiting5 trials
- Terminated3 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Incyte Corporation4 trials
- AB Science1 trial
- Cantargia AB1 trial
- Celgene1 trial
- Daiichi Sankyo1 trial
- and 12 more
Running trials
Recruiting
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Recruiting
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Recruiting
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Bladder cancer2 recruiting
- Colorectal cancer2 recruiting
- Cervical cancer1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Withdrawn
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
Completed
Completed
Terminated
Terminated
Completed
Completed
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
Terminated
Completed
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Completed
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026